Twist Bioscience Corp.

{
  "main_header": {
    "sid": 1238375,
    "name": "Twist Bioscience Corp.",
    "stock_name": "Twist Bioscience Corp.",
    "full_name": "Twist Bioscience Corp.",
    "name_url": "stocks-analysis/twist-bioscience-corp",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "42.94",
    "chg": 9.58,
    "chgp": "28.72%",
    "dir": 1,
    "prev_price": "33.36",
    "mcapval": "2,669.11",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US90184D1000",
    "curr_date": "Jan 23",
    "curr_time": "",
    "bse_nse_vol": "751.02 k",
    "exc_status": "Active",
    "traded_date": "Jan 23, 2026",
    "traded_date_str": "2026 01 23",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/twist-bioscience-corp-1238375-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Twist Bioscience Corp. Hits Day High with 9.55% Surge in Stock Price",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/twist-bioscience-corp-hits-day-high-with-955-surge-in-stock-price-3726114",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TwistBioscience_priceRelatedfactors_3726114.png",
        "date": "2025-11-24 16:45:15",
        "description": "Twist Bioscience Corp. saw a notable increase in stock performance on November 21, 2025, reaching an intraday high. The company reported a 17.91% growth in net sales, reflecting positive operational momentum, while maintaining high institutional holdings at 100%, indicating strong investor confidence despite longer-term challenges."
      },
      {
        "title": "Twist Bioscience Stock Hits Day Low of $25.51 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/twist-bioscience-stock-hits-day-low-of-2551-amid-price-pressure-3712571",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TwistBioscience_priceRelatedfactors_3712571.png",
        "date": "2025-11-18 17:25:40",
        "description": "Twist Bioscience Corp. has faced significant stock volatility, with notable declines over various timeframes, including a 32.08% drop over the past year. Despite these challenges, the company reported a 17.91% increase in net sales and maintains strong institutional holdings at 100%."
      },
      {
        "title": "Twist Bioscience Opens Weak with 10.57% Gap Down Amid Market Concerns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/twist-bioscience-opens-weak-with-1057-gap-down-amid-market-concerns-3712555",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TwistBioscience_gapdown_3712555.png",
        "date": "2025-11-18 17:14:17",
        "description": "Twist Bioscience Corp. experienced a notable decline in its stock performance, contrasting with the broader market's stability. Over the past month, the company has faced a significant drop, with mixed technical indicators suggesting varying trends. Its market capitalization is around USD 1,584 million, and it does not offer dividends."
      },
      {
        "title": "Twist Bioscience Stock Hits Day Low of $23.50 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/twist-bioscience-stock-hits-day-low-of-2350-amid-price-pressure-3707972",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TwistBioscience_priceRelatedfactors_3707972.png",
        "date": "2025-11-17 17:04:57",
        "description": "Twist Bioscience Corp. faced a notable stock decline today, reflecting ongoing market challenges. Despite a significant drop in stock performance over various timeframes, the company reported a 17.91% increase in net sales as of June 25 and maintains full institutional ownership. Key financial metrics indicate a negative return on equity."
      },
      {
        "title": "Twist Bioscience Corp. Hits New 52-Week Low at $23.50",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/twist-bioscience-corp-hits-new-52-week-low-at-2350-3707951",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/TwistBioscience_priceRelatedfactors_3707951.png",
        "date": "2025-11-17 16:41:58",
        "description": "Twist Bioscience Corp. has hit a new 52-week low, reflecting a difficult year with a significant stock price decline. The company, categorized as small-cap with a market capitalization of USD 1,584 million, is currently loss-making and exhibits negative financial metrics, highlighting challenges in the biotechnology sector."
      },
      {
        "title": "Twist Bioscience Stock Soars 7.16%, Hits Intraday High of $34.18",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/twist-bioscience-stock-soars-716-hits-intraday-high-of-3418-3649337",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/TwistBioscience_priceRelatedfactors_3649337.png",
        "date": "2025-10-27 17:37:39",
        "description": "Twist Bioscience Corp. has seen a notable increase in stock performance, with significant gains over the past week and month. The company reported strong net sales growth and maintains high institutional holdings. However, it faces challenges with declines over the past year and year-to-date."
      }
    ],
    "total": 15,
    "sid": "1238375",
    "stock_news_url": "https://www.marketsmojo.com/news/twist-bioscience-corp-1238375"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Twist Bioscience Corp. Hits Day High with 9.55% Surge in Stock Price

2025-11-24 16:45:15

Twist Bioscience Corp. saw a notable increase in stock performance on November 21, 2025, reaching an intraday high. The company reported a 17.91% growth in net sales, reflecting positive operational momentum, while maintaining high institutional holdings at 100%, indicating strong investor confidence despite longer-term challenges.

Read full news article

Twist Bioscience Stock Hits Day Low of $25.51 Amid Price Pressure

2025-11-18 17:25:40

Twist Bioscience Corp. has faced significant stock volatility, with notable declines over various timeframes, including a 32.08% drop over the past year. Despite these challenges, the company reported a 17.91% increase in net sales and maintains strong institutional holdings at 100%.

Read full news article

Twist Bioscience Opens Weak with 10.57% Gap Down Amid Market Concerns

2025-11-18 17:14:17

Twist Bioscience Corp. experienced a notable decline in its stock performance, contrasting with the broader market's stability. Over the past month, the company has faced a significant drop, with mixed technical indicators suggesting varying trends. Its market capitalization is around USD 1,584 million, and it does not offer dividends.

Read full news article

Twist Bioscience Stock Hits Day Low of $23.50 Amid Price Pressure

2025-11-17 17:04:57

Twist Bioscience Corp. faced a notable stock decline today, reflecting ongoing market challenges. Despite a significant drop in stock performance over various timeframes, the company reported a 17.91% increase in net sales as of June 25 and maintains full institutional ownership. Key financial metrics indicate a negative return on equity.

Read full news article

Twist Bioscience Corp. Hits New 52-Week Low at $23.50

2025-11-17 16:41:58

Twist Bioscience Corp. has hit a new 52-week low, reflecting a difficult year with a significant stock price decline. The company, categorized as small-cap with a market capitalization of USD 1,584 million, is currently loss-making and exhibits negative financial metrics, highlighting challenges in the biotechnology sector.

Read full news article

Twist Bioscience Stock Soars 7.16%, Hits Intraday High of $34.18

2025-10-27 17:37:39

Twist Bioscience Corp. has seen a notable increase in stock performance, with significant gains over the past week and month. The company reported strong net sales growth and maintains high institutional holdings. However, it faces challenges with declines over the past year and year-to-date.

Read full news article

View All News